DES
Basic information
Region (hg38): 2:219418377-219426735
Links
Phenotypes
GenCC
Source:
- atrioventricular block (Strong), mode of inheritance: AD
- atrioventricular block (Strong), mode of inheritance: AR
- myofibrillar myopathy 1 (Definitive), mode of inheritance: Semidominant
- dilated cardiomyopathy 1I (Strong), mode of inheritance: AD
- familial isolated dilated cardiomyopathy (Supportive), mode of inheritance: AD
- neurogenic scapuloperoneal syndrome, Kaeser type (Supportive), mode of inheritance: AD
- dilated cardiomyopathy 1I (Definitive), mode of inheritance: AD
- myofibrillar myopathy 1 (Definitive), mode of inheritance: AD
- myofibrillar myopathy 1 (Definitive), mode of inheritance: AR
- dilated cardiomyopathy 1I (Strong), mode of inheritance: AD
- myofibrillar myopathy 1 (Strong), mode of inheritance: AD
- myofibrillar myopathy 1 (Strong), mode of inheritance: AR
- dilated cardiomyopathy (Definitive), mode of inheritance: AD
- arrhythmogenic right ventricular cardiomyopathy (Moderate), mode of inheritance: AD
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Myopathy, myofibrillar 1; Cardiomyopathy, dilated, 1I | AD/AR | Cardiovascular | In myofibrillar myopathy, individuals typically present with slowly progressive weakness, and a significant proportion of individuals demonstrate cardiomyopathy, such that surveillance for arrhythmia or conduction defects may allow early treatment (eg, pacemaker, ICD); Cardiac transplantation may be necessary in individuals with severe forms of cardiomyopathy; In dilated cardiomyopathy, surveillance (eg, with electrocardiogram and echocardiogram) can allow early detection and interventions (including medications) in order to ameliorate morbidity and mortality | Cardiovascular; Musculoskeletal; Neurologic | 5828910; 8114783; 7672786; 9697706; 9736733; 10430757; 10545598; 11073539; 17221859; 17439987; 19433360; 19879535; 20301672; 20664348; 20718792; 22215463; 23687351; 24200904; 31024060 |
ClinVar
This is a list of variants' phenotypes submitted to
- Desmin-related myofibrillar myopathy (39 variants)
- not provided (15 variants)
- Dilated cardiomyopathy 1I;Desmin-related myofibrillar myopathy;Neurogenic scapuloperoneal syndrome, Kaeser type (2 variants)
- Primary dilated cardiomyopathy;Desmin-related myofibrillar myopathy (1 variants)
- Neurogenic scapuloperoneal syndrome, Kaeser type (1 variants)
- Dilated cardiomyopathy 1I (1 variants)
- Primary dilated cardiomyopathy (1 variants)
- Myofibrillar myopathy (1 variants)
- Cardiovascular phenotype (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the DES gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 10 | 189 | 204 | |||
missense | 10 | 22 | 469 | 503 | ||
nonsense | 12 | 21 | ||||
start loss | 2 | |||||
frameshift | 14 | 26 | ||||
inframe indel | 20 | 24 | ||||
splice donor/acceptor (+/-2bp) | 15 | |||||
splice region | 1 | 21 | 17 | 39 | ||
non coding | 13 | 79 | 16 | 109 | ||
Total | 40 | 47 | 526 | 270 | 21 |
Highest pathogenic variant AF is 0.0000329
Variants in DES
This is a list of pathogenic ClinVar variants found in the DES region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
2-219418389-C-T | Neurogenic scapuloperoneal syndrome, Kaeser type • Dilated cardiomyopathy 1I • Myofibrillar Myopathy, Dominant • Desmin-related myofibrillar myopathy | Uncertain significance (Jan 12, 2018) | ||
2-219418409-C-T | Dilated cardiomyopathy 1I • Neurogenic scapuloperoneal syndrome, Kaeser type • Desmin-related myofibrillar myopathy | Uncertain significance (Jan 13, 2018) | ||
2-219418416-C-T | not specified | Likely benign (Mar 08, 2018) | ||
2-219418419-G-A | not specified • Myofibrillar Myopathy, Dominant • Dilated cardiomyopathy 1I • Neurogenic scapuloperoneal syndrome, Kaeser type • Desmin-related myofibrillar myopathy | Benign/Likely benign (Apr 27, 2017) | ||
2-219418432-T-A | Likely benign (Apr 03, 2018) | |||
2-219418432-T-TGCGCCCGCCAGCC | not specified | Benign (Oct 19, 2020) | ||
2-219418446-T-TGCGCCCGCCAGCC | Benign (Mar 03, 2015) | |||
2-219418454-G-A | not specified | Uncertain significance (Feb 11, 2022) | ||
2-219418456-C-G | not specified • Dilated cardiomyopathy 1I | Conflicting classifications of pathogenicity (Jul 25, 2019) | ||
2-219418457-G-A | Dilated cardiomyopathy 1I • Neurogenic scapuloperoneal syndrome, Kaeser type • Myofibrillar Myopathy, Dominant • not specified • Desmin-related myofibrillar myopathy | Uncertain significance (Feb 01, 2021) | ||
2-219418461-C-T | Cardiomyopathy | Uncertain significance (-) | ||
2-219418463-A-G | Desmin-related myofibrillar myopathy • Cardiovascular phenotype | Conflicting classifications of pathogenicity (May 17, 2024) | ||
2-219418464-T-C | Desmin-related myofibrillar myopathy | Likely pathogenic (Jun 29, 2020) | ||
2-219418467-G-T | Desmin-related myofibrillar myopathy | Pathogenic/Likely pathogenic (Feb 08, 2023) | ||
2-219418469-C-G | DES-related disorder | Uncertain significance (Dec 29, 2023) | ||
2-219418469-C-T | Desmin-related myofibrillar myopathy | Pathogenic/Likely pathogenic (May 04, 2023) | ||
2-219418470-A-G | Desmin-related myofibrillar myopathy | Uncertain significance (Oct 03, 2022) | ||
2-219418471-G-A | Cardiovascular phenotype • Desmin-related myofibrillar myopathy | Likely benign (Dec 01, 2023) | ||
2-219418472-G-A | Desmin-related myofibrillar myopathy | Uncertain significance (Dec 21, 2020) | ||
2-219418473-C-A | Desmin-related myofibrillar myopathy | Uncertain significance (Mar 12, 2022) | ||
2-219418474-C-A | Desmin-related myofibrillar myopathy • Cardiovascular phenotype | Likely benign (Dec 17, 2023) | ||
2-219418474-C-G | Desmin-related myofibrillar myopathy | Likely benign (Feb 03, 2020) | ||
2-219418477-C-A | Cardiovascular phenotype | Uncertain significance (Jan 23, 2023) | ||
2-219418479-C-G | Desmin-related myofibrillar myopathy • Cardiovascular phenotype | Uncertain significance (Oct 12, 2021) | ||
2-219418479-C-T | Desmin-related myofibrillar myopathy | Uncertain significance (Jan 09, 2018) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
DES | protein_coding | protein_coding | ENST00000373960 | 9 | 8363 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.00883 | 0.991 | 125726 | 0 | 22 | 125748 | 0.0000875 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.77 | 206 | 291 | 0.708 | 0.0000191 | 2986 |
Missense in Polyphen | 79 | 106.97 | 0.73855 | 1097 | ||
Synonymous | 1.11 | 108 | 124 | 0.873 | 0.00000789 | 923 |
Loss of Function | 3.05 | 8 | 24.2 | 0.331 | 0.00000141 | 249 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000123 | 0.000123 |
Ashkenazi Jewish | 0.000827 | 0.000794 |
East Asian | 0.000116 | 0.000109 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000703 | 0.0000703 |
Middle Eastern | 0.000116 | 0.000109 |
South Asian | 0.0000327 | 0.0000327 |
Other | 0.000163 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: Muscle-specific type III intermediate filament essential for proper muscular structure and function. Plays a crucial role in maintaining the structure of sarcomeres, inter-connecting the Z-disks and forming the myofibrils, linking them not only to the sarcolemmal cytoskeleton, but also to the nucleus and mitochondria, thus providing strength for the muscle fiber during activity (PubMed:25358400). In adult striated muscle they form a fibrous network connecting myofibrils to each other and to the plasma membrane from the periphery of the Z-line structures (PubMed:24200904, PubMed:25394388, PubMed:26724190). May act as a sarcomeric microtubule-anchoring protein: specifically associates with detyrosinated tubulin-alpha chains, leading to buckled microtubules and mechanical resistance to contraction. Contributes to the transcriptional regulation of the NKX2-5 gene in cardiac progenitor cells during a short period of cardiomyogenesis and in cardiac side population stem cells in the adult. Plays a role in maintaining an optimal conformation of nebulette (NEB) on heart muscle sarcomeres to bind and recruit cardiac alpha-actin (By similarity). {ECO:0000250|UniProtKB:P31001, ECO:0000269|PubMed:24200904, ECO:0000269|PubMed:25394388, ECO:0000269|PubMed:26724190, ECO:0000303|PubMed:25358400}.;
- Disease
- DISEASE: Myopathy, myofibrillar, 1 (MFM1) [MIM:601419]: A form of myofibrillar myopathy, a group of chronic neuromuscular disorders characterized at ultrastructural level by disintegration of the sarcomeric Z disk and myofibrils, and replacement of the normal myofibrillar markings by small dense granules, or larger hyaline masses, or amorphous material. MFM1 is characterized by skeletal muscle weakness associated with cardiac conduction blocks, arrhythmias, restrictive heart failure, and accumulation of desmin-reactive deposits in cardiac and skeletal muscle cells. {ECO:0000269|PubMed:10545598, ECO:0000269|PubMed:10717012, ECO:0000269|PubMed:10905661, ECO:0000269|PubMed:11061256, ECO:0000269|PubMed:11668632, ECO:0000269|PubMed:12620971, ECO:0000269|PubMed:12766977, ECO:0000269|PubMed:14648196, ECO:0000269|PubMed:14711882, ECO:0000269|PubMed:14724127, ECO:0000269|PubMed:15495235, ECO:0000269|PubMed:15800015, ECO:0000269|PubMed:16009553, ECO:0000269|PubMed:16376610, ECO:0000269|PubMed:16865695, ECO:0000269|PubMed:17221859, ECO:0000269|PubMed:18061454, ECO:0000269|PubMed:19879535, ECO:0000269|PubMed:20829228, ECO:0000269|PubMed:22106715, ECO:0000269|PubMed:22395865, ECO:0000269|PubMed:23615443, ECO:0000269|PubMed:25394388, ECO:0000269|PubMed:27733623, ECO:0000269|PubMed:28470624, ECO:0000269|PubMed:9697706, ECO:0000269|PubMed:9736733}. Note=The disease is caused by mutations affecting the gene represented in this entry. Mutations in the DES gene are associated with a variable clinical phenotype which encompasses isolated myopathies, pure cardiac phenotypes (including dilated cardiomyopathy, restrictive cardiomyopathy and arrhythmogenic right ventricular cardiomyopathy), cardiac conduction disease, and combinations of these disorders. If both cardiologic and neurologic features occur, they can manifest in any order, as cardiologic features can precede, occur simultaneously with, or follow manifestation of generalized neuromuscular disease (PubMed:19879535). {ECO:0000269|PubMed:19879535}.; DISEASE: Cardiomyopathy, dilated 1I (CMD1I) [MIM:604765]: A disorder characterized by ventricular dilation and impaired systolic function, resulting in congestive heart failure and arrhythmia. Patients are at risk of premature death. {ECO:0000269|PubMed:10430757, ECO:0000269|PubMed:24200904, ECO:0000269|PubMed:26724190}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Neurogenic scapuloperoneal syndrome Kaeser type (Kaeser syndrome) [MIM:181400]: Autosomal dominant disorder with a peculiar scapuloperoneal distribution of weakness and atrophy. A large clinical variability is observed ranging from scapuloperoneal, limb grindle and distal phenotypes with variable cardiac or respiratory involvement. Facial weakness, dysphagia and gynaecomastia are frequent additional symptoms. Affected men seemingly bear a higher risk of sudden, cardiac death as compared to affected women. Histological and immunohistochemical examination of muscle biopsy specimens reveal a wide spectrum of findings ranging from near normal or unspecific pathology to typical, myofibrillar changes with accumulation of desmin. {ECO:0000269|PubMed:17439987, ECO:0000269|PubMed:25394388}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Limb-girdle muscular dystrophy 2R (LGMD2R) [MIM:615325]: A form of limb-girdle muscular dystrophy, a disease characterized by proximal weakness, weakness of the hip and shoulder girdles and prominent asymmetrical quadriceps femoris and biceps brachii atrophy. {ECO:0000269|PubMed:23687351}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
- Pathway
- Dilated cardiomyopathy (DCM) - Homo sapiens (human);Arrhythmogenic right ventricular cardiomyopathy (ARVC) - Homo sapiens (human);Hypertrophic cardiomyopathy (HCM) - Homo sapiens (human);Arrhythmogenic Right Ventricular Cardiomyopathy;Striated Muscle Contraction;Striated Muscle Contraction;Muscle contraction;Aurora B signaling
(Consensus)
Recessive Scores
- pRec
- 0.122
Intolerance Scores
- loftool
- 0.0939
- rvis_EVS
- -0.51
- rvis_percentile_EVS
- 21.56
Haploinsufficiency Scores
- pHI
- 0.787
- hipred
- Y
- hipred_score
- 0.790
- ghis
- 0.575
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.785
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Des
- Phenotype
- cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); muscle phenotype; homeostasis/metabolism phenotype; cellular phenotype;
Zebrafish Information Network
- Gene name
- desma
- Affected structure
- cardiac muscle cell
- Phenotype tag
- abnormal
- Phenotype quality
- decreased amount
Gene ontology
- Biological process
- muscle contraction;cytoskeleton organization;regulation of heart contraction;muscle filament sliding;intermediate filament organization
- Cellular component
- nucleus;cytosol;intermediate filament;fascia adherens;intercalated disc;Z disc;neuromuscular junction;sarcolemma;intermediate filament cytoskeleton;extracellular exosome;cardiac myofibril
- Molecular function
- structural constituent of cytoskeleton;protein binding;cytoskeletal protein binding;identical protein binding